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ABSTRACT
Mitochondria are cell organelles involved in processes of cell life and death, and
therefore also in tumoral transformation. Indeed, mitochondria dysfunction is a prominent
feature of cancer cells. Mitochondrial proteins and DNA have also been previously studied
as markers of tumorigenesis.
Heat shock proteins (HSPs) are ubiquitous evolutionary conserved proteins. HSPs
enhance their expression in stressed cells and they are involved in gene expression regulation,
DNA replication, signal transduction, differentiation, apoptosis, cellular senescence or
immortalization.
This review reflects recent views on the role of some mitochondrial molecular chaperones
as prohibitin, mortalin and HSP60/HSP10 complex and their modifications leading to
cell transformation and cancer development. These molecules could represent modern
molecular biomarkers for oncological management.
INTRODUCTION
A Neoplasm is a cell mass consisting of abnormal cells that have evolved in a process of
cell transformation; it may also be defined as a heritably altered, relatively autonomous
growth of tissue with abnormal regulation of gene expression. Factors of transformation
are genetic and epigenetic changes leading to deregulation of cell proliferation, differenti-
ation and adhesion.1 Although human cells spontaneously immortalize in vitro with very
limited probability, transformation with SV40 (large T antigen), papillomavirouses (E6
and E7 genes) or adenoviruses (E1A and E1B genes) are common triggers of immortal-
ization. Until now, many studies on immortalization have been focused on telomere
shortening, p53, pRb/p16INK-4 pathways, so it would seem that immortalization is
achieved by p53 or pRb function abrogation on one hand or activation of telomerase on
the other.2,3 One of the cell organelle involved in the process of cell life and death, and
therefore also in cell transformation and clonal evolution is the mitochondrium.4-6
Mitochondria (from Greek mitos thread + khondrion granule) are semiautonomous rod-
shaped, round organelles of Eucaryotic cells carrying their own genome and protein
translation machinery. Mitochondria, like nuclei, are bounded by a double membrane.
This is one of the relicts of endosymbiosis of Purple NonSulfur Photosynthetic Bacteria
(Rhodospirillaceae) within pro-Eucaryotic cells. Human mitochondrial DNA contains
16,569 base pairs organized in a closed circle7 and encodes for 13 polypeptides, 22tRNAs
and 2 rRNAs.5,6,8 Mitochondria are also called “cellular power plants,” as the primary
function of these organelles is to produce ATP in the process of oxidative phosphorylation
(OXPHOS). At the same time, many housekeeping metabolic reactions take place in this
cell compartment, including production of intermediates of carbohydrates, nucleotides,
fatty acids and aminoacids metabolism. Mitochondria are irrelevant proto folio because of
their key role in homeostasis, which is probably the reason of their maintenance within
cells lacking mtDNA (ρo).6,8,9 Climatic adaptation, ageing, longevity, degenerative disease
and cancer are only few of the processes which mitochondria are assigned to.8,10
Today we know that mitochondria dysfunction is one of the most prominent features
of cancer cells. Mitochondria failure, damage or dysfunction has been reported on all
levels of their biogenesis, structure and physiology (Fig. 1). The situation is further
complicated by the mitochondria-nucleus interaction, and homo- and heteroplasmy of
cells.5,11 Some of the processes that mitochondria are involved in or that take place
within mitochondria have been widely studied for many years; these include OXPHOS
and apoptosis.12-14 Other processes, such as protein import, and complex assembly, have
not yet been adequately described and further experiments need to be performed to put all
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the fragmentary data into one functional model.15,16 Mitochondria,
mtDNA and mitochondrial proteins have been already recognized as
important in the process of establishment of new markers of tumori-
genesis in the era of molecular medicine also by clinicians, and
therapies have been individually adjusted for specific patients. In
many medical reports, a strong correlation between mitochondria
function and cancer development has already been pointed out. A
vast amount of clinical data provides evidence of mtDNA as cancer
markers.17-19 For some types of cancer, a specific pattern of mtDNA
mutations has been assigned.17,20 This review represents the current
knowledge on mitochondrial molecular chaperones such as prohibitin,
mortalin and Hsp60/Hsp10 and their role in mitochondria function,
focusing on the alterations in expression and function modifications
that may lead to cell transformation and cancer development.
HEAT SHOCK PROTEINS
Heat shock proteins (HSPs) are ubiquitous and evolutionary
conserved proteins, that were first discovered as heat shock triggers
over 40 years ago.21 Their fundamental role in cellular homeostasis
and cell viability was recognized in 1962 when F. Ritossa exposed
Drosophila to 37˚C for 30 min. and proteins of 70 and 26 kDa were
highly expressed, suggesting they are indispensable to overcome heat
stress, which was later confirmed.21 HSPs are functionally related
proteins classified into families according to molecular weight. In
most organisms stress proteins are represented by families of
HSP100, HSP90, HSP70, HSP60 and small HSPs, with several
members in each class. Proteins are affiliated to these diverse groups
of molecular chaperones by their capacity to recognize and bind
substrate proteins that are in an unstable or inactive state.22
Initially, chaperones were associated only with protein folding,22
but they are now recognized as key players in a wide spectrum of
processes. HSPs act as molecular chaperones assisting in protein
transport, oligomeric proteins and protein complexes assembly,
refolding of misfolded proteins20 and triggers of degradation by
proteosome.23 Chaperone proteins adhere to hydrophobic sites on
newly synthesized or unfolded proteins, thus preventing the formation
of functionless aggregates by random adhesion to hydrophobic sites
on other proteins. Some of the HSPs also function as unfoldases of
aggregated polypeptides, which means that they reactivate heat-
inactivated proteins that can subsequently assume their proper
configuration after disengagement, as they are given a second chance
for folding. Chaperonin-mediated protein folding is explained by
two models—the “Anfinsen cage” and the “iterative annealing”. The
first model proposes that chaperonins provide a passive box, where
folding proceeds because no intermolecular interactions disrupt the
process and off-pathway aggregation reactions are prevented. The
second assumes that ATP - dependent cycles of forced unfolding of
energetically trapped intermediates accelerates native conformation
acquisition.22
HSPs are present in all cell compartments—cytosol, mitochon-
dria, ER and nucleus, and typically they have a long half-life.
Different chaperone proteins cooperate in building a network to assist
polypeptides in the maintenance of native conformation. HSPs seem
to accumulate in a dosage-dependent manner to amounts that are
sufficient to protect cells against imbalance in the protein folding
status of the cellular proteome.24,25 Although HSPs are highly
expressed in stressed cells and could be considered only as cell stress
“buffers”, they are also involved in gene expression regulation, DNA
replication, signal transduction,26 differentiation, apoptosis, cellular
senescence or immortalization.27 In the last few years numerous
experiments have shown chaperones involvement in cell transforma-
tion, metastasis formation and multidrug-resistence development.26-28
At the same time, they have been shown to be involved in immune
response stimulation, leading to the development of the symptoms
of infectious and autoimmune diseases.29
HSP60: WHEN THE DEVIL SITS BEHIND THE CROSS
Human heat shock protein 60—Hsp60 (CPN60, GROEL,
HSP60, HSP65, HuCHA60 or SPG13) is encoded by a nuclear
gene HSPD1 (GeneID: 3329) localized on chromosome 2q33.1. It
is also designated as P60 lymphocyte protein, chaperonin, heat shock
60 kD protein 1, heat shock protein 65, mitochondrial matrix
protein P1 or short heat shock protein 60 Hsp60s1. Two pseudo-
genes, located on chromosome 8, have been associated with this
gene.30 In normal cells, Hsp60 is mostly localized in the mitochondrial
matrix, in the outer mitochondrial membrane and, less frequently, in
extra-mitochondrial sites.31 Hsp60 is constitutively expressed under
normal conditions, and induced by heat shock, mitochondria
damage and mtDNA depletion. Its transcription is regulated by a
HSE (heat shock element) acting on a bidirectional promoter.32
Chaperonin primary function is the assistance in mitochondrial
protein folding, unfolding and degradation.22,33,34 The involvement
of Hsp60 in the process of apoptosis and tumorigenesis is now under
investigation.
First report suggesting that Hsp60 was involved in apoptosis was
published by Samali et. al. These authors showed that activation of
caspase-3 by staurosporine occurs simultaneously with Hsp60 and
Hsp10 release from mitochondria in Hela and Jurkat T cells.
Furthermore, in vitro and in vivo, Hsp60 and Hsp10 have been shown
to associate with pro-caspase3 and possibly accelerate its activation.35
On the other hand, Kirchhoff et al have argued an anti-apoptotic
role of cytosolic Hsp60 in cardiac myocytes.36 The authors demon-
strated that Hsp60 interacts with pro-apoptotic Bax and Bak
proteins thus preventing apoptosis onset. In their experiments,
reduced Hsp60 expression led to an increase in the number of Bax
protein associated with a mitochondrial membrane fraction. Since
Bax alone is sufficient to induce cytochrome c release and subse-
quently induce apoptosis, Hsp60-Bax interaction may be considered
as critical in preventing apoptosis in normal cells.36
The exact molecular role of Hsp60 is still far from being com-
pletely understood. Interactors reported to date include basic metab-
olism proteins that are probably substrates of Hsp60 such as a
chaperone like aldehyde dehydrogenase 2, carbonic anhydrase II,
dihydrofolate reductase, and its partner in mitochondrial protein
folding mtHsp70 and heat shock 10kDa protein 1, but also proteins
Figure 1. Levels of mitochondria dysfunctions found in cancer cells. 
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involved in apoptosis and cell cycle regulation, like BCL2 antagonist
killer 1, caspase 3 preproprotein, caspase 6 isoform alpha prepro-
protein, caspase 9 isoform alpha preproprotein, p21ras, H2B histone
family, member Q, Alpha 3 beta 1 integrin and PKA C.22,36-39
Indeed, the actions of HSP60 could lead to the modification of
those proteins and, due to their role in cell cycle regulation, influence
the carcinogenesis, and the mitochondrial regeneration during normal
cell proliferation.
In recent studies, we have focused on the presence and the expres-
sion of Hsp60 in carcinogenic models: the adenoma-carcinoma
sequence of colorectum and the dysplasia-carcinoma sequence of
uterine exocervix and prostate. Using immunohistochemical and
western blotting analyses, we found that Hsp60 expression gradually
increases from normal through dysplastic to neoplastic tissues, arguing
that its overexpression during carcinogenesis may be functionally
correlated to tumoral growth. Our attention is now focused on the
overexpression of Hsp60 which can be used as a molecular marker
of clinical stage and patient prognosis in a variety of tumors and
pretumoral lesions, i.e., adrenal Cushing tumors,40 human breast
ductal carcinoma,41 large bowel,42,43 bronchial,44 exocervical45 and
prostate46 carcinogenesis. Hsp60 expression has also been suggested
as a good prognostic marker in human oesophageal squamous cell
carcinoma (ESCC).47 In this study the Authors have hypothesised
that Hsp60 expression correlates with the apoptotic index and
patient outcome in ESCC.
The literature reported thus far has led us to consider Hsp60 as a
carcinogenesis marker, with a potential clinical significance.
Although the exact molecular details of Hsp60 actions have not been
defined to date, it is reasonable to think that its expression may serve
as a prognostic tool in clinics and histopathologic diagnostics. In
summary, these studies demonstrate that hsp60 might significantly
contribute to tumorigenesis, making it a good candidate target for
cancer therapy.
HSP10: WHEN SMALL IS NOT ALWAYS BEAUTIFUL
Heat shock 10 kDa protein 1 (Hsp10, CPN10, GROES) is
encoded by a nuclear gene HSPE1 (GeneID: 3336) localized on
chromosome 2q33.1. It is also designated as chaperonin 10, and it
is translated in the cytoplasm and transported into mitochondria.
Although in normal cells Hsp10 is localized mostly in the mito-
chondrial matrix, it has also been found in other sub-cellular local-
izations, such as zymogene granules, hormone granules, secretory
granules and mature red blood cells.48 For many years Hsp10 has
been mostly considered a partner of Hsp60 in the Hsp60/10 protein
folding machine. Chaperonin complex structure was resolved at
high resolution, and detailed descriptions of the chaperonin mediated
folding cycle have been proposed by different research groups.22,33,49
The Hsp60/10 complex is believed to be responsible for acceler-
ating the folding of polypeptides imported into, and translated within,
mitochondria, reactivation of denaturated proteins, diminishing
aggregation of nonnative polypeptides and partially unfolded
kinetically trapped intermediates. It is believed that it has the power
to smooth the ‘energy landscape’ of protein folding as it prevents
intermolecular interactions between nonnative polypeptides.22,33,49
As a partner of Hsp60, Hsp10 participates in protein complex
assembly, intra-mitochondrial sorting and biogenesis of mitochondria.
Hsp10 binds Hsp60 in the presence of Mg-ATP suppressing the
ATPase activity of the latter and participating in the encapsulation
of the substrate.50
So far, little is known either about the physical interactions of
human Hsp10 with other proteins within the cell, or its involvement
in signal transduction pathways. Most of the data available describe
a well known interaction of Hsp10 with Hsp60 in a barrel-like structure
of multi-subunit chaperon machine involved in protein folding.22
This interaction has been widely studied in E. coli, S. cerevisiae and
human cells.51 A recent report by Lin et al suggested an interaction
of human Hsp10 with Ras GTP-ase pathway in myocyte protection
after ischemia/reoxygenation insult.52 Other proteins that have been
reported to interact with HSP10 are mitochondrial aldehyde
dehydrogenase 2 protein family member, and caspase 3 prepropro-
tein.35 It is not possible to exclude that interference of Hsp10 with
the signalling pathway might play a specific role in anti-apoptotic
protection, which is supported by the involvement of Hsp10 in
post-ischemic cell viability.52 It has only been proven that individual
overexpression of chaperonins may protect cells from ischemia-
reoxygenation induced cell death. It has also been shown that
Hsp10/60 accumulation is caused by increased transcription and
translation of the protein, as Hsp10 mRNA is induced following
global brain ischemia.53 In the myocardium of patients with chronic
atrial fibrillation, the expression of the mitochondrial heat shock
proteins HSP60 and HSP10 is increased, as well as in brain stem
after subarachnoid haemorrhage.54,55 It has been proposed that
myocyte protection by Hsp10 involves the mobile loop and attenu-
ation of the Ras GTP-ase pathway.38 Hsp10 could also influence the
function of signaling proteins, according to Shan et al.56 In this
study, overexpression of Hsp10 was shown to increase the abundance
of IGF-1R and IGF-1-stimulated receptor auto-phosphorylation,
the number of functioning receptors and to amplify activation of
IGF-1R signaling. Hsp10 has also been suggested to be able to
suppress poly-ubiquitination of IGF-1 receptor.56 Moreover, Hsp10
has been shown to modulate the Bcl-2 family and mitochondria
apoptosis signalling in cardiac muscle cells. Overexpression of Hsp10
increases the abundance of anti-apoptotic Bcl-xl and Bcl-2, reduces
the protein content of the pro-apoptotic Bax, but does not alter the
expression of Bad. Finally, HSP10 stabilizes mitochondrial
cross-membrane potential, inhibits caspase-3, and suppresses
PARP.56
In the human body, Hsp10 is upregulated by neuronal vesicular
cell trafficking and synaptic plasticity,57 and it is able to stimulate the
synthesis of type I collagen.58 Concerning cell proliferation and
maturation, HSP10 plays a role in bone marrow cell differentiation,
and is selectively overexpressed in myeloid and megakaryocytic
precursors in normal human bone marrow.59
The overexpression of Hsp10 has been reported in a variety of
tumours and pretumoral lesions, such as large bowel, exocervical,
and prostate cancer.43,46,60 Again, it may be postulated that Hsp10
expression may serve as a marker in tumor grading and staging.
MORTALIN: WHEN A CLOSE FRIEND BECOMES A CLOSE ENEMY
Mitochondrial heat shock 70kDa-mtHsp70 (CSA, GRP75, HSPA9,
MGC4500, MOT, MOT2, MTHSP75, PBP74, mot-2) is encoded
by the nuclear gene HSPA9B (GeneID: 3313) localized on chromosome
5q31.1.1. It is also designated as 75 kDa glucose regulated protein,
heat shock 70kD protein 9, heat shock 70kD protein 9B, mortalin-2,
heat shock 70kDa protein 9B, mortalin, perinuclear protein, p66-mor-
talin, peptide-binding protein 74 and stress-70 protein. It is translated
in the cytoplasm and transported into mitochondria.61 Mammalian
mitochondrial Hsp70-mortalin- mot-1 was cloned in mice due to its
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detection in the cytoplasmatic fraction of immortal cells, and it was
then referred as an anti-proliferative protein. Human cells express
only one type of mortalin protein, hmot-2.62 Mortalin is distributed
in a pancytoplasmatic manner in normal cells, but in immortal cells
this localization changes into the perinuclear zone and it may reverse
to normal cell pattern after induction of senescence.63
Known interactors of mortalin include metabolic enzymes, such
as diphosphomevalonate decarboxylase, structural mitochondrial
proteins, such as the voltage-dependent anion channel 1, and
proteins involved in cell survival and differentiation, like the fibroblast
growth factor 1, mitogen-activated protein kinase kinase kinase 7
isoform B, mitogen-activated protein kinase kinase kinase 7 inter-
acting protein 2 isoform 1, tumor rejection antigen 1, and above all
p53.62,64,65
Colocalization of p53 and mortalin in the perinuclear region has
been shown in many types of cancer cells such as NIH 3T3 (murine
fibroblasts, wt p53), Balb/3T3 (immortalized cell line), HeLa (cervical
carcinoma, wt p53), A2182 (bladder carcinoma, wt p53), U2OS
(osteosarcoma, wt p53), A172 (glioblastoma, wt p53), NT-2 (terato-
carcinoma, wt p53), SY-5Y and YKG-1 (neuroblastoma, wt p53),
COS7 (monkey kidney), and MCF7 (breast carcinoma).61,65
Available data suggest that mot-2 is somehow also responsible for
the reduction of the stable pool of p53, as it might be involved in
repression of PT53 transcription or p53 degradation.65 Mot-2
operates as an inhibitor of p53 function, by sequestering it in the
cytoplasm and decreasing p53-target genes expression (e.g.,
p21SD11/WAF). It is highly probable that mortalin functions in the
same manner as its cytoplasmatic homolog, hsp70, binding p53 in
the cytoplasm and sequestering it, which leads to abrogation of p53
function.66 An even more pronounced impact of mot-2 overexpression
and interaction with p53 is observed in immortal cells as NIH 3T3,
where it changes the cell phenotype from immortal to malignant.
Overexpressed mot-2 may also cause a temporary escape of human
fibroblast (MRC-5) from senescence, leading to increased replicative
potential (9 to 17 PD population doublings extra), maintenance of
young cell morphology, and reduced expression of β-galactosidase
(senescent cells marker).67
The role of mtHsp70 was likewise widely explored in the context
of cell proliferation and differentiation; an example is the acute
myeloid leukemia HL-60 cell line: when these cells undergo differ-
entiation, mtHSP70 is downregulated, whereas Hsp70, Hsc70 and
Grp78 expression is not changed.68 The overexpression of mtHsp70
in HL-60 cells attenuates the differentiation process induced by RA,
1,25(OH)2D3 or NMF. On the other hand, the constitutive expres-
sion of inducible hsp70 has been shown to prevent the apoptosis
that occurs after terminal differentiation or after apoptotic agent
treatment.68 Overexpression of mortalin is also sufficient to increase
the malignancy of breast carcinoma cells. Moreover, cells with an
increased expression of mortalin may be anchorage-independent and
acquire the ability to form tumours in nude mice.69
Mortalin expression has been reported in all the 60 tissues
checked so far.63,69 Highest level of mortalin has been shown in
brain, heart muscle tissue, and skeletal muscles; in contrast, lowest
levels were detected in testis and spleen. Higher levels of mortalin are
reported in tissues characterized by high mitotic index, which
confirms the anti-proliferative role of this protein.61,65 To date,
mortalin overexpression has been proven in many cancers types
including brain tumours and B cell lymphoma. It is reasonable to
consider its overexpression as a universal marker of cell transformation.65
All data presented so far, reveal that mortalin contributes to human
carcinogenesis and may be a candidate for gene therapy.69
PROHIBITIN NOT ALWAYS PROHIBITS CANCER DEVELOPMENT
Human prohibitins (hPhb1p and hPhb2p) are encoded by two
nuclear genes PHB and PHB2 (GeneID: 5245 and 1331, respectively)
localized on chromosome 17q21 and 12p13. PHB is expressed as
two transcripts with varying lengths of the 3' untranslated region.
Both PHBs are translated in the cytoplasm and transported into
mitochondria.70 Prohibitins primary function is to stabilize new
synthesized polypeptides in mitochondria, as they serve as foldase-
unfoldase molecular chaperones.71,72 hPhb1p and hPhb2p localize
in the inner mitochondrial membrane (IM) forming a 1MD complex,
composed of 14 subunits (hPhb1p-32 kDa, hPhb2p-34 kDa) in a
1:1 ratio.70,72-74 The name of the protein refers to its chaperone
function—proteins that hold badly formed subunits.72,73 The
substrates of the PHB complex are not known in details yet, but the
most important seem to be electron chain transport subunits.72,74
The Palisade shaped model suggests that the prohibitin complex
forms a barrel like structure, similar to Hsp60.74 In the regulation of
mitochondrial protein metabolism the most important seems to be
PHB AAA-proteases interaction. AAA-proteases are evolutionary
conserved ATP-dependent proteases of the inner mitochondrial
membrane with a catalytic site in the mitochondrial matrix (m-AAA)
and intermembranous space (i-AAA).15,75,76
It seems that PHBs are negative regulators of m-AAA-proteases
and PHBs stabilize m-AAA proteases in low activity conformation.
PHBs are also able to modulate accessibility and conformation
potential substrates of proteases.15,72,75,76 PHBp have also been
recognized as negative regulators of cell cycle.68,71 It was established
that PHBS are overexpressed in metabolic stress, when the
mtDNA/nDNA balance is altered, after heat shock or oxidative
stress.73 To date, prohibitins have been proposed to be active players
in cell growth, ageing and transformation.72
Clinical data suggest a possible role of prohibitin during immor-
talization, ageing and cell cycle regulation. PHBs have been reported
to have an anti-proliferative potential and its function have been
proven to be deregulated in breast cancer patients.71 Wide investiga-
tion of PHB expression revealed that it is constitutively expressed in
normal mammalian cells as hepatocytes, smooth muscle cells,
chondrocytes, spermatocytes or oocytes. Higher levels of prohibitin
expression were found in regenerating liver cells, chemically induced
carcinoma, hyperplastic hepatic nodules and hepatocellular carcino-
mas, and in cancer cells lines and primary tumour samples.72,73 In
detail, PHBs have been reported to be overexpressed in hepatocellular
carcinoma cell line (HCC-M),77 human endometrial hyperplasia
and adenocarcinoma,72 gastric cancer,78 13 breast cancer cell lines,72
and bladder cancer (86). The etiology of PBH overexpression seems
to originate from myc-binding elements found in the promoter
region of PHB, whereas c-myc oncogene is overexpressed in many
cancer cells and may facilitate PBH expression.72,73 Decline of PHB
expression seems to induce cell ageing, that has also been confirmed
by studies on fibroblasts.79
Although many cancer cell lines and tumour samples, including
breast, ovarian, hepatic and lung cancer, have been tested for phb
gene mutations, so far only sporadic breast cancer samples seem to
be positive, whereas loss of heterozygosity (LOH) has been reported,
although it needs to be taken into account that not all the gene
sequence has been tested.80,81 It seems that genotyping prohibitin
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may be a prognostic marker in breast cancer in women before 50
years of age.82
Besides its chaperone activity prohibitin has to be classified as an
antiapoptotic protein.73 Its interaction with pRb protein has already
been widely explored.83 Transcription factor E2F (regulated by pRb)
interacts with PHB leading to cell cycle block,83 due to E2F inacti-
vation mediated by pRb, p107 and p130.84 PHB inhibits transcription
induced by E2F1,2,3,4 and 5 and it is thought to be an active player
in cell signalling cascades.83 Moreover, PHB interaction with SV40
T antigen has been reported,84 and PHB localized in the nucleus
was reported to mediate histone deacethylation.83 PHB is also able
to inhibit DNA synthesis in fibroblasts and HeLa cells.
Overexpression of PHB protects B lymphocytes against apoptosis
mediated by topoisomerase inhibitors.81 It has been proven that
PHB mRNA can regulate genes expression.85 Microinjection of
PHB mRNA blocks S phase entry in HeLa cells and fibroblasts.
Further investigations have proven that PHB 3’UTR encodes for an
RNA molecule that inhibits the G1/S transition and that mutations
in that region can abolish anti-proliferative action. C to T transition
in PHB mRNA 3'UTR modulates its function and increases the risk
of breast cancer development in women under 50 years if age.86
Plenty of fragmentary data on PHB action do not seem to give a
relevant answer to its role in cancer development and progression.
PHB mitochondrial localization and its chaperon function supports
the hypothesis that it is actively involved in cell transformation, but
further experiments might reveal its secrets and confirm it as a good
candidate for molecular medicine and gene therapy.15,66,74
CONCLUSIONS
Molecular biology data suggest that cell transformation and
immortalization are not controlled by a simple, single mechanism.
Those processes are driven by the complex interplay of many genes
functioning in multiple pathways. The best known cell cycle regula-
tors, such as p53, pRb or telomerase must be considered as the
contributors of clonal evolution and un-differentiation.2,87 It seems
that we are just beginning to uncover the molecular background of
the tumorigenesis process, its constituents, their role and mode of
action. A large body of evidences accumulated during the last few
years stresses out that mitochondrial molecular chaperones have to
be considered as an indispensable kink of this regulatory network.
Many laboratories consistently indicate that mitochondrial heat
shock proteins may play a unique role in cell transformation and
cancer development (Fig. 2). Chaperones, through their ability to
renaturate or disassemble protein aggregates, interact with other stress-
response mechanisms such as superoxide dismutases or transcription
factors, inducing reciprocal effects on cell life.69 As repeatedly
demonstrated, HSPs function as molecular chaperones in regulating
cellular homeostasis, promote cell survival and may influence
apoptosis.27,88 Various studies demonstrate that HSP-induced
cytoprotection is partly due to the suppression of apoptosis.89 Since
apoptosis represents the negative counterpart of proliferation, defects
in apoptosis are associated with maintenance of a transformed state
and cancer. Therefore, chaperone action may represent continuous
transition from stress protection to cell transformation. Even though
cell stress and cell death are obviously linked, molecular chaperones
induced in response to stress appear to function at key regulatory
points in the control of apoptosis. Considering the main role of
molecular chaperones in the regulation of steroid receptors, kinases,
caspases, transcription factors and other protein modelling events
involved in replication, cell cycle and differentiation, it is not sur-
prising that the overexpression of these molecules has been proven to
trigger cancer development.69 Because cell stress and cell death are
likely to have multiple points of regulatory cross-talk, the balance
between the two pathways depends on the specific nature and inten-
sity of the stress and the level and activity of individual components
of the pathway. Disruption of such a delicate balance may end up
with dramatic effects as insoluble proteins association, onset of
enzymatic activity at inappropriate times, incorrect localization
within the cell, or any combination of the above mentioned situa-
tions.27 Recently many interesting observations have been made.
The contribution of HSPs to tumorigenesis has been attributed to
their pleiotropic activities as molecular chaperones that provide the
cell with an opportunity to alter protein activities, in particular
components of the cell machinery as transcription factors (mortalin
interacting with p53) or kinases (mortalin interacting with mitogen-
activated protein kinase kinase kinase 7 isoform B and mitogen-acti-
vated protein kinase kinase kinase 7 interacting protein 2 isoform 1).
Chaperones may alter cell function by associating with vital cellular
proteins (mortalin-p53; prohibitin-pRB) and modulating the func-
tion of proteins that are involved in the elimination of malignant
cells.83 This could be possible since they participate in the folding of
numerous proto-oncogene and oncogene products, as well as
other proteins involved in signal transduction (e.g., fibroblast
growth factor 1).
All the molecular data suggest that mitochondrial chaperones are
involved in cell transformation processes. Although it is not possible
to find a clear and uniform model for tumorigenesis, the role of
Hsp60, Hsp10, mortalin and prohibitin should not be underesti-
mated. At the same time, data collected during the last few years may
justify the application of HSPs expression patterns in molecular
pathologic diagnostics. The last 30 years have brought dynamic
development of molecular biology methods, medicine and pharmacol-
ogy. The last 10 years have proven that basic life sciences may have a
tremendous impact on medicine, diagnostics and patient treatment.
It is possible to develop efficient therapies and prognostic markers if
the effort of many disciplines is put together.
Figure 2. Co-dependence between cell transformation and clinical and
molecular diagnostics. 
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